CA Patent

CA2872002C — Pyrazole derivative and use thereof for medical purposes

Assigned to Kissei Pharmaceutical Co Ltd · Expires 2019-01-15 · 7y expired

What this patent protects

The present invention provides: a pyrazole derivative; a use of the pyrazole derivative for medical purposes; and others. More specifically, the present invention relates to a medicinal agent useful for the prevention or treatment of constipation, which comprises 3-(3-{4-[3-(ß-D-…

USPTO Abstract

The present invention provides: a pyrazole derivative; a use of the pyrazole derivative for medical purposes; and others. More specifically, the present invention relates to a medicinal agent useful for the prevention or treatment of constipation, which comprises 3-(3-{4-[3-(ß-D-glucopyranosyloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide or a pharmacologically acceptable salt thereof as an active ingredient. The medicinal agent according to the present invention has an activity of increasing stool frequency and the like and is therefore effective for the prevention or treatment of constipation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2872002C
Jurisdiction
CA
Classification
—
Expires
2019-01-15
Drug substance claim
No
Drug product claim
No
Assignee
Kissei Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.